In a world where numerous industries are reevaluating the transformative potential of artificial intelligence (AI), the pharmaceutical sector is already experiencing revolutionary changes in drug discovery. Companies like GSK and
Pharmaceutical12- Page
192Articles
The fate of AstraZeneca’s planned £450 million investment in a vaccine manufacturing facility in northwest England hangs in the balance as the Treasury, under the leadership of Chancellor Rachel Reeves,
The National Health Service (NHS) has announced a groundbreaking initiative to tackle the growing threat of antimicrobial resistance (AMR) by partnering with the pharmaceutical industry. The NHS will negotiate fixed-fee
A pharmaceutical giant will test an experimental treatment in response to the surge in demand for obesity treatments Pfizer has accelerated the trials of a weight loss pill that can
Arecor Therapeutics PLC, listed on AIM as AREC, has been making waves in the healthcare industry with its innovative approach to diabetes and obesity treatments. In a recent interview with
After Emmanuel Macron’s charm offensive, the two largest pharmaceutical companies in Britain have committed £430m to France. AstraZeneca, GSK and other pharmaceutical companies have pledged to upgrade their facilities within
Imaging Biometrics, a subsidiary of IQ-AI Ltd, has recently made a significant announcement regarding its lead drug candidate, IB-003. The US Food and Drug Administration (FDA) has granted Rare Pediatric
Shield Therapeutics, a pharmaceutical company focusing on iron deficiency treatments, has reported a significant increase in revenues for the year 2023. The company’s sales of its Accrufer/Feraccru iron deficiency treatment
Sir John Bell, one of Britain’s leading life sciences leaders, warned of an imminent exodus of pharmaceutical companies from London, calling the City “a bad place to raise funds”. Sir
Novo Nordisk’s attempts to alleviate global shortages of the “wonder drug”, which it claims to be a weight-loss miracle, have led them to a businesspark on the outskirts Dublin. Last
Novo Nordisk’s shares reached a new record high following the Danish company’s report of soaring sales for its obesity and diabetic drugs Wegovy, and Ozempic. This pushed its market value
Haleon sold ChapStick for more than $500m as it sought to reduce its debts while also boosting its stock price. The FTSE-100 company has agreed that it will sell its
Syntara's $10M capital raise is propelling its drug development strategy into a new era. In this exclusive interview, CEO Gary Phillips unveils the transformative steps taken by Syntara Ltd, from its rebranding efforts to the strategic deployment of funds.
Boots, the US-owned high street pharmacy chain, is considering a £7bn UK IPO. This could give London’s struggling stock market a needed boost. Walgreens Boots Alliance, which abandoned its plan
Novo Nordisk wants to help more people get Wegovy jabs, including those who are currently unable to access them. Novo Nordisk, a maker of obesity drugs, said that it would
The landscape of vaccine technology is witnessing a revolutionary change with the introduction of TNX-1800, a next-generation COVID-19 vaccine developed by Tonix Pharmaceuticals. Led by CEO Dr. Seth Lederman, the
